Trilliome Wins 1st Prize in EIT Food’s “Food as Medicine” Accelerator and Expands Global Recognition

We are thrilled to announce that Trilliome has won 1st prize in the EIT Food Accelerator Network’s “Food as Medicine” programme, receiving €50,000 in Tech Validation Funding.

This recognition highlights our mission to develop precision bioactives that reprogram the gut microbiome to restore brain and immune health for healthy aging. The funding will accelerate the next phase of validation for our AI-driven discovery platform, which transforms upcycled plant sources into targeted gut bioactives that address key mechanisms of human health and resilience.

A Breakout Year for Trilliome

2025 has been a milestone year for Trilliome.
In addition to the EIT Food “Food as Medicine” Accelerator 1st prize, we also earned the 2nd prize at the Aging Research and Drug Discovery (ARDD) Conference — one of the world’s leading events in longevity science — and the Probiota Americas Pioneer Prize for innovative product development in the microbiome field.

Together, these recognitions underscore our unique position at the intersection of biotechnology, nutrition, and healthy aging, and validate our approach to redefining how food and bioactives can power measurable health outcomes.

Turning Plant Waste into Human Health

At Trilliome, we believe the next revolution in health begins in the gut.
Our proprietary AI and human gut model platform identifies molecular combinations that reprogram the microbiome — boosting keystone bacterial species and restoring functions linked to brain and immune health.

Our lead bioactive product is derived from upcycled fruit and plant waste streams, a circular approach that supports both human health and planetary sustainability. Early studies in human models show a massive boost gut bacteria associated with neuroprotection, mood regulation, and a significant increases in short-chain fatty acids (SCFAs) such as butyrate and propionate, which are key to cognitive health, mood regulation, and immune balance.

By uniting science, sustainability, and social impact, Trilliome is redefining what “Food as Medicine” means for the future of health and longevity.

Accelerating Toward Measurable Impact

Winning the EIT Food Tech Validation Award provides critical support as we advance toward clinical validation, scalable GMP manufacturing, and regulatory readiness. These milestones will accelerate our path to market, enabling partnerships in the B2B ingredients, supplements, and medical foods sectors worldwide.

Each of these awards — from ARDD’s recognition in longevity research to Probiota’s innovation prize and EIT Food’s Tech Validation Award — reinforces our commitment to translating molecular science into real-world health solutions.

We are deeply grateful to our partners, mentors, and the EIT Food Accelerator Network for their support. Together, we are building a future where nutrition and biotechnology converge to create measurable health outcomes and healthy longevity for all.

The future of food and health is one, and it is accelerating.

The Trilliome Team

🔗 Learn more about EIT Food’s Tech Validation Funding here
🔗 Visit www.trilliome.com to explore our work